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Abstract
Objectives: Despite well-known fitness advantages to males who produce and maintain high
endogenous testosterone levels, such phenotypes may be costly if testosterone-mediated invest-
ment in reproductive effort trade-off against investment in somatic maintenance. Previous studies
of androgen-mediated trade-offs in human immune function find mixed results, in part because
most studies either focus on a few indicators of immunity, are confounded by phenotypic correla-
tion, or are observational. Here the association between male endogenous testosterone and 13
circulating cytokines are examined before and after ex vivo antigen stimulation with phytohemag-
glutinin (PHA) and lipopolysaccharides (LPS) in a high pathogen population of Bolivian forager-
horticulturalists.
Materials and methods: A Milliplex 13-plex cytokine panel measured cytokine concentration in
whole blood samples from 109 Tsimane men aged 40–89 (median550 years) before and after
antigen stimulation with PHA and LPS. Urinary testosterone was measured via enzyme immunoas-
say, demographic, and anthropometric data were collected as part of the Tsimane Health and Life
History Project.
Results: Higher endogenous testosterone was associated with down-regulated responses in all
cytokines after PHA stimulation (but significantly in only 2/13 cytokines), controlling for age and
body mass index. In contrast, testosterone was not significantly associated with down-regulation
of cytokines after LPS stimulation. MANOVAs indicate that men with higher testosterone showed
reduced cytokine responses to PHA compared with LPS (p50.0098).
Discussion: Endogenous testosterone appears to be immunomodulatory rather than immunosup-
pressive. Potentially costlier forms of immune activation like those induced by PHA (largely T-cell
biased immune activation) are down-regulated in men with higher testosterone, but testosterone
has less impact on potentially less costly immune activation following LPS stimulation (largely
B-cell mediated immunity).
K E YWORD S
immunocompetence handicap hypothesis, lipopolysaccharides (LPS), phytohemagglutinin (PHA),
testosterone, Tsimane
1 | INTRODUCTION
Trade-offs between reproduction and longevity are among the most
comprehensively researched areas of life history theory (Boddy, Kokko,
Breden, Wilkinson, & Aktipis, 2015; Kirkwood & Rose, 1991; Muehlen-
bein & Bribiescas, 2005). Testosterone and other steroid hormones
play critical roles in the development and maintenance of many
sexually dimorphic traits in males resulting from sexual selection
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(Andersson, 1994), but at a cost; ceteris paribus, energetic investments
in reproductive effort trade-off against investments in somatic mainte-
nance (Folstad & Karter, 1992; Muehlenbein & Bribiescas, 2005). Since
fitness gains of investment in reproduction earlier in life often out-
weigh the gains from somatic repair, reproduction is usually prioritized
over longevity. Natural and controlled experiments provide evidence in
favor of testosterone-mediated male survival, with castrated males liv-
ing longer than intact males across many species including humans
(Min, Lee, & Park, 2012).
One of the costlier forms of somatic investment in adulthood is
immune function (Straub, Cutolo, Buttgereit, & Pongratz, 2010; Zuk &
Stoehr, 2002). Immune activation increases resting metabolism in
humans and other species by 8%–56%, and can incur caloric costs of
up to 2,000 kJ/day21 (Demas, Greives, Chester, & French, 2011; Dert-
ing & Compton, 2003; Muehlenbein, Hirschtick, Bonner, & Swartz,
2010; Straub et al., 2010). The Immunocompetence Handicap Hypoth-
esis (ICHH) rose out of classical life-history theory and decades of
research into costly signaling to become a dominant framework in the
evolutionary ecology and behavioral endocrinology literature. It pro-
poses that testosterone—as a critical mediator of male reproductive
effort—suppresses immune function, and thus elaborate androgen-
based traits represent an honest signal of male quality since only high
quality males can afford to incur such costs (Folstad & Karter, 1992;
Furman et al., 2013; Zuk & Stoehr, 2002). While the ICHH is a domi-
nant theoretical model in the life history literature, evidence in favor of
this hypothesis is limited, and other lines of research have suggested
alternative models to explain associations between androgens and
immune function (Foo, Nakagawa, Rhodes, & Simmons, 2016; Nunn,
Lindenfors, Pursall, & Rolff, 2009).
The immunosuppressive effects of exogenously administered testos-
terone are well documented from experimental studies of nonhuman
animal models (Duffy, Bentley, Drazen, & Ball, 2000; Peters, 2000;
Poiani, Goldsmith, & Evans, 2000; Yao, Liang, Han, & Hou, 2003). How-
ever, recent studies and meta-analyses find mixed evidence that endog-
enous testosterone is an active immunosuppressant in free-living
mammals (Foo et al., 2016; Nunn et al., 2009; Roberts, Buchanan, &
Evans, 2004). In fact, naturalistic studies often show positive associa-
tions between endogenous testosterone and induced antibody
response, suggesting that males in good condition can afford to main-
tain both high testosterone levels and robust immune responses (i.e.,
positive phenotypic correlations) (Peters, 2000; Rantala et al., 2012).
These findings are bolstered by experimental work in a reptile model
showing that immune function is enhanced when exogenous testoster-
one is paired with food supplementation, but without food supplemen-
tation exogenous testosterone results in decreased innate immune
function (Ruiz, French, Demas, & Martins, 2010). Importantly, testos-
terone is down-regulated following infection and tissue injury, making
it difficult to isolate the effects of testosterone on immune function in
cross-sectional studies (Christeff, Benassayag, Carli-Vielle, Carli, &
Nunez, 1988; Spratt, Cox, Orav, Moloney, & Bigos, 1993; Spratt et al.,
2006). While meta-analyses suggest that testosterone is overall immu-
nosuppressive (Foo et al., 2016), there is still ambiguity depending on
which aspects of immune function are studied, and whether the
impacts of testosterone on immune function are direct or indirect.
Another major issue is that most studies assessing trade-offs
between immune function and testosterone rely on only a single bio-
marker of immune function, precluding the ability to examine a poten-
tial immunomodulatory role of testosterone. Immune function involves
multiple coordinated responses, each with their own costs, benefits
and interactions with other immune and endocrine responses. Numer-
ous cytokines, for example, play critical roles in immune cell signaling
and lymphocyte differentiation and have varying impacts on physiology
and varying energetic costs (Table 1). As an alternative to the ICHH, it
has been proposed that testosterone is immuno-modulatory rather than
immunosuppressive, that is, testosterone regulates trade-offs between
different types of immune response (Muehlenbein & Bribiescas, 2005;
Simmons & Roney, 2009). If only the energetically costlier forms of
immunity are downregulated in higher testosterone males, then ener-
getic availability may underlie some of the associations reported in the
literature. Indeed, evidence suggests that energetic costs (e.g., from ill-
ness, fasting) can impact both testosterone levels and immune function
(Scrimshaw & SanGiovanni, 1997; Spratt et al., 1993; Trumble, Brindle,
Kupsik, & O’connor, 2010). The ability to mount a rapid response to
local infection or tissue injury is of particular utility, as high testoster-
one males more frequently engage in aggressive physical competition
with other males (Archer, 2006). In mandrills, male–male competition in
the form of physical aggression is a common route for spreading simian
immunodeficiency virus (SIV) (Nerrienet et al., 1998), while physically
aggressive interactions between wild rodent males increase transmis-
sion rates of hantavirus (Glass, Childs, Korch, & LeDuc, 1988). Innate
immune responses, which include pro- and anti-inflammatory cyto-
kines, not only are crucial rapid responses to injury, but also play a role
in subsequent wound healing (Werner & Grose, 2003). In free-ranging
baboons, where success in male–male physical conflict determines
males’ reproductive access to females, high status males—who have
higher testosterone than subordinate males (Gesquiere et al., 2011)—
heal faster than subordinates (Archie, Altmann, & Alberts, 2012), per-
haps because of positive phenotypic correlation. Thus, while there may
be trade-offs between testosterone and some more energetically costly
aspects of immune function (Best & Hoyle, 2013), one would not
expect that testosterone would down-regulate all aspects of immune
function equally.
Studying the role of testosterone in modulating immune function
under naturalistic conditions is notoriously difficult in humans, where
ethical concerns limit the use of various experimental protocols com-
monly used in nonhuman animal models. Observational studies demon-
strate that testosterone decreases immediately following illness or
injury (Christeff et al., 1988; Muehlenbein et al., 2010; Spratt et al.,
1993, 2008), which is consistent with a life history framework which
posits that energetic stress shunts caloric resources from investment in
reproductive effort (often proxied by a high testosterone phenotype)
toward immune function. While it is clear that any energetic stress,
whether due to immune activation from infection (Muehlenbein et al.,
2010) or caloric restriction (Trumble et al., 2010), results in decreased
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testosterone production, it is less clear that endogenous testosterone
actively down-regulates human immune function. Indeed, a longitudinal
study of Filipino males found a positive association between testoster-
one and immunoglobulin A (sIgA), a marker of mucosal immunity (Get-
tler, McDade, Agustin, Feranil, & Kuzawa, 2014).
1.1 | Study goals and hypotheses
This study contributes to the literature with (1) data from a free-living
energy limited population living a relatively traditional lifestyle, (2) use of
multiple measures of immune activation, and (3) measurement of bio-
markers at baseline and following an ex vivo challenge. The analyses
herein focus on 109 older adult men (aged 40–89 years, median age550
years) in a population of forager horticulturalists facing high pathogen
burden (Gurven, Kaplan, Winking, Finch, & Crimmins, 2008). In this
immunologically stressed population, we expect energetic trade-offs
between testosterone and immune function to be stronger than that
observed among energetically replete industrialized populations with
lower infectious burden (Blackwell et al., 2015; Gurven et al., 2008). Addi-
tionally, industrialized populations have significantly higher levels of tes-
tosterone at younger ages compared with subsistence populations, and
steeper age-related declines (Ellison et al., 2002; Trumble et al., 2012).
Most prior observational studies in humans have only measured
circulating concentrations of immune markers under baseline condi-
tions, as opposed to the immune response to challenge. Recent studies
indicate that immune response to challenge is far costlier than baseline
immune function, both in nonhuman animal models (Demas et al.,
2011; Derting & Compton, 2003) and humans (Muehlenbein et al.,
2010). Given behavioral effects of androgens (e.g., Archer, 2006), indi-
viduals with higher testosterone may also engage in behavior that
increases the likelihood of wounding or encountering pathogens (e.g.,
increased male–male competition) (Klein, 2000).
In this study, levels of urinary testosterone are examined in rela-
tion to 13 circulating cytokines following ex vivo whole blood antigen
stimulation with a T-cell mitogen, phytohemagglutinin (PHA) and a
B-cell mitogen, lipopolysaccharides (LPS). PHA is a commonly used
mitogen that activates the division and replication of T-cells, while LPS
is a cell wall component of gram negative bacteria that binds to toll-like
receptor 4 (TLR4) and initiates B-cell division and differentiation into
plasma cells as well as activation of macrophages, monocytes, and den-
dritic cells (Ceuppens, Baroja, Lorre, Van Damme, & Billiau, 1988; Heu-
mann & Roger, 2002; Wheelock, 1965). This study can therefore
examine androgen mediated immuno-modulation in response to sev-
eral common immune challenges facing humans. This experimental
approach has major advantages; first, we are able to stimulate an
immune response ex vivo which permits intra- and inter-individual com-
parisons in cytokine response to the same challenge controlling for
baseline cytokine levels and other potential confounders. Additionally,
while under normal physiological conditions circulating testosterone
rapidly decreases following infection or tissue injury (Christeff et al.,
1988; Simmons & Roney, 2009; Spratt et al., 1993, 2008), using an ex
vivo design we can examine the relationship between baseline testos-
terone and cytokine response to stimulation without any potential for
steroidal down regulation post-infection.
Given the advantages of this experimental design over previous
observational studies, we hypothesize that we will have a level of
TABLE 1 Cytokine response to antigen type, see Figure 1
Response to mitogen Cytokine Produced By Role
IL-2 T cells Triggers T-cells to become effector cells,
expansion of T-cell clones
Stronger PHA
cytokine response
IL-4 Basophils may be initial
effector, Th2 cells (auto)
Differentiates B cells to plasma cells,
B-cell IgE class switching
IL-13 T cells Induce IgE secretion, physiological
changes in parasitized organs
IL-5 T cells, Eosinophils B-cell growth, Ig secretion, Eosinophil activation
Intermediate response
to both PHA and LPS
IL-7 Dendritic cells, NOT lymphocytes Proliferation of all lymphocytes
INF-g NK and NKT cells, Th1 CD4
and CD8 effector cells
Activates macrophages, inhibits viral replication
GM-CSF Macropahges, T cells, Mast Cells, NK Cells Granulocyte and monocyte production
IL-8 Macrophages Neutrophil chemotaxis
IL-6 T cells, macrophages Energy mobilization, temperature increase,
B cell growth, T-reg antagonism
IL-12p70 Dendritic cells, macrophages,
immature B cells
T cell growth, UP IFN-g, TNF-a from T and NK,
down IL-4. Increases toxicity of NK and
CD8. IL-2 ups IL-12 receptors, enhancing the effect
Stronger LPS
cytokine response
IL-10 Monocytes, Th2 (less), Treg,
cytotoxic T-cells to inhibit NK in
response to virus
Negative feedback on self, down regulates
MHC II, Enhances B cell, down regulates
IFN-g, IL-2,IL-3, TNF-a, GM-CSF
TNF-a Macrophages, CD4, NK Fever, inflammation, apoptosis
IL-1b Activated macrophages Lymphocyte activator
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contrast necessary to differentiate between broad immunosuppression
versus immunomodulation of specific aspects of immune function. We
hypothesize that higher endogenous testosterone will be associated
with more down-regulation of energetically costly aspects of immune
function, such as T-cell mediated immune responses, but not broad,
generalized immunosuppression.
2 | MATERIALS AND METHODS
2.1 | Ethics statement
For all protocols institutional (UCSB and UNM) IRB approval was
granted, as was informed consent at three levels: (1) Tsimane govern-
ment that oversees projects, (2) village leadership, and (3) study
participants.
2.2 | Bio-specimen collection and preparation
Tsimane men (n5122) came to the Tsimane Health and Life History
Project’s (THLHP) clinic in San Borja, Beni, Bolivia to participate in
THLHP protocols (e.g., economic and demographic interviews, biospe-
cimen collection), and to receive a routine medical exam as part of the
project’s behavioral–biomedical surveillance. All Tsimane aged 401
were invited to participate in this and other studies regardless of their
health status, and approximately 85% of adults participated. Prior to
the medical exam and interviews, men provided a first morning void
urine specimen. Fasting blood was drawn, both with and without hepa-
rin as an anti-coagulant. One vacutainer of blood without anti-
coagulant was allowed to clot, and then serum was separated via cen-
trifugation (1,500g 3 10 minutes) and frozen in liquid nitrogen. Multi-
ple 100 mL aliquots of heparinized whole blood were immediately
added to separate round bottom microtiter wells in a sterile 96-well
plate. The first aliquot received 100 mL of 20 mg/mL phytohaemaggluti-
nin (PHA, Sigma cat. 61764) diluted in RPMI-1640, for a final concen-
tration of 10 mg/mL PHA. The second aliquot received 100 mL of 20
mg/mL Lipopolysaccharides (LPS. Sigma cat. L2630) diluted in RPMI-
1640, for a final concentration of 10 mg/mL LPS. A third aliquot was
mixed with 100 mL RPMI-1640 without mitogens. In all three cases,
RPMI was supplemented with 100 IU/mL penicillin and 100 lg/mL
streptomycin (Sigma cat. P0781) to prevent contamination. In the
absence of a CO2 incubator in the San Borja clinic, the microtiter plate
was sealed in a glass Tupperware with a lit candle, which burned the
O2 in the container, thus enriching the CO2 concentration (May et al.,
2009). The sealed plates were incubated at 378C for 72 hr. Following
this, the supernatant was removed and frozen in liquid nitrogen for
transport to UNM. Specimens were transported on dry ice and stored
at2808C for up to 2 years before assay.
2.3 | Biomarkers of immune activation
Immediately following the blood draw, leukocyte counts were meas-
ured with a QBC Autoread Plus (QBC Diagnostics). For both baseline
(unstimulated) serum specimens and post-stimulation whole blood
specimens, 13 cytokines (TNF-a, INF-g, IL-1b, Il-2, IL-4, IL-5, IL-6, IL-7,
IL-8, IL-10, IL-12p70, IL-13, and GM-CSF) were measured with a Milli-
plex MAP High-Sensitivity Human Cytokine Panel (HSCYTO-60, Milli-
pore Corp., Billerica, MA) on the Luminex MagPix, at the Hominoid
Reproductive Ecology Laboratory at the University of New Mexico.
Following manufacturer recommendation, calibrators were prepared
with a serum matrix for baseline specimens, and with RPMI for
antigen-stimulated samples, and specimens below the limits of detec-
tion were assigned the lower limit of detection. Quality control speci-
mens were within expected ranges provided by the manufacturer.
C-Reactive Protein (CRP) was measured at the UCSB Human Bio-
demography lab via enzyme immunoassay (Brindle, Fujita, Shofer, &
O’connor, 2010). Within and between plate coefficients of variation
(CVs) were 7.3% and 10.2% for the high and 5.3% and 9.2% for the
low controls.
2.4 | Urinary testosterone
Though both urine and serum samples were obtained, we elected to
assess testosterone in urine because urine samples reflect testosterone
production over a longer period and are less susceptible to transient
fluctuations. Since a large proportion of testosterone in urine is present
in its conjugated form of testosterone glucuronide, we first deconju-
gated samples with beta-glucuronidase (Helix pomatia, Calbiochem,
<2% aryl sulfatase activity) and ether extraction. Testosterone was
measured with an in-house enzyme linked immunosorbent assay
(ELISA) using a polyclonal antibody (R156/7, provided by C. Munro at
the University of California-Davis) which cross reacts 100% with tes-
tosterone, 57.4% with 5a-dihydrotestosterone, 0.27% with androste-
nedione, and less than 0.05% with other androgens (Muir, Spironello-
Vella, Pisani, & deCatanzaro, 2001). Within and between plate CVs
were 4.7% and 12.2% for the high and 4.7% and 14.9% for the low
controls. Urinary testosterone was corrected for specific gravity (Miller
et al., 2004).
2.5 | Statistical methods
From the initial sample of 122, males with acute infections (CRP
>10 mg/L, n512), were removed prior to analyses. Additionally, one
individual was missing testosterone data. Three individuals were miss-
ing PHA stimulation data and six individuals LPS stimulation data, due
to contamination of samples during field procedures. Final sample sizes
were 103 for LPS analyses, 106 for PHA analyses, and 109 for com-
bined analyses. Cytokines (baseline and ex vivo stimulated) and testos-
terone values were logged to normalize distributions unless otherwise
noted, and converted to Z-scores. Cytokines were normalized across all
stimulation conditions to place all cytokines on a similar scale, and
allow for simultaneous testing of effects across multiple cytokines. A
second set of z-scores were also normalized only within a particular
stimulation type, to allow comparison of relative cytokine changes
under particular mitogen stimulation conditions. Models reported in
the article indicate which z-scores were utilized for a particular analysis.
Mitogen stimulations were run in batches on a given day, and each
batch was grouped together and treated as a random effect to control
4 | TRUMBLE ET AL.
for potential non-independence due to field conditions (e.g., tempera-
ture fluctuations) or plate characteristics. Linear mixed model analyses
examined associations between mitogen type, cytokine type, testoster-
one, and cytokine response, controlling for age, BMI, CRP, and baseline
cytokines as fixed effects, and subject and batch as random effects,
using lme in the nlme package in R. Models were fit with restricted
maximum likelihood (REML). We then used anova on our lme models to
assess significance of multilevel factors (Pinheiro & Bates, 2006). Addi-
tional exploratory linear mixed effects regression models examined
associations between testosterone and each individual cytokine
response to both PHA and LPS stimulation (z-scored), controlling for
fixed effects of age, BMI, CRP and baseline cytokine, and a random
effect of batch. We utilize an a50.05 as the cutoff for statistical signif-
icance. The p-values are not Bonferroni corrected as the tests are not
independent (cytokines interact and covary), violating the independ-
ence requirement of a Bonferroni correction. Interaction terms (e.g.
testosterone by BMI) were assessed, but did not achieve statistical sig-
nificance and are thus omitted. Statistical analyses were conducted in
R 3.2.2 (https://cran.r-project.org/).
3 | RESULTS
3.1 | Testosterone and baseline characteristics
Urinary testosterone was not associated with baseline immune param-
eters, including overall baseline serum cytokines (b50.026, t50.44,
p5 .658) or any individual cytokine level (all p’s>0.19). Baseline total
leukocyte (b520.011, t520.05, p50.962) counts were not associ-
ated with testosterone level.
3.2 | Cytokine response to T- and B-cell mitogens
Cytokine responses to each of the mitogens are categorized in Figure 1A
and Tables 2–6 and S1-4. Comparing across mitogens, cytokine
responses differ significantly (p< .001) between PHA and LPS stimulation
(Table 3; Figure 1A), with PHA characterized by high IL-2, IL-4, IL-5, and
IL-13, and LPS characterized by high IL-12p70, IL-10, TNFa, and IL-1 b.
The remaining cytokines (IL-7, INF- g, GM-CSF, IL-8, IL-6) showed inter-
mediate responses to both mitogens (Figure 1A). There was no clear
trend for the RPMI only stimulation condition (Figure 1A).
3.3 | Impact of endogenous testosterone on the
cytokine response to T- and B-cell mitogens
Testosterone was a significant predictor of overall cytokine response
to PHA (b520.131, t522.01, p50.049), although the effect is not
specific to particular cytokines (no significant interaction with cytokine
type; Table 2). Testosterone was not a significant predictor of overall
cytokine response to LPS (b520.003, t520.06, p50.479). These
results were unchanged when controlling for leukocyte count (Support-
ing Information Table S1).
Testosterone levels interacted with mitogen stimulation type;
there was a negative testosterone by PHA interaction (Table 3). Higher
testosterone is generally associated with lower cytokine production
FIGURE 1 Mean normalized cytokine levels under each stimulation condition relative to normalized testosterone. Conditions include
medium only (RPMI) or stimulation with a B-cell and monocyte (LPS) or a T-cell mitogen (PHA). (A) Mean cytokine levels for each stimula-
tion condition. Each cytokine is normalized across all conditions in order to show variation across stimulation types, while eliminating the
absolute differences in level between different cytokines. (B) Mean cytokine levels within each stimulation condition, relative to testoster-
one level. Cytokines are normalized within each mitogen condition to show only variation associated with testosterone. Higher testosterone
is generally associated with lower cytokine production after PHA stimulation and in RPMI medium alone. All z-scores were calculated by
first logging cytokine or testosterone values, and then subtracting the mean and dividing by the standard deviation. Both A and B show the
predicted values from the mixed models shown in Table 3, controlling for BMI, baseline serum cytokine levels, baseline CRP, and analysis
batch
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after PHA stimulation and in RPMI medium alone. Normalizing for
stimulation type illustrates this further (Figure 1B), by illuminating only
the testosterone-associated variance in cytokine levels.
3.4 | Testosterone and individual cytokine response to
ex vivo antigen stimulation
Our models suggested that effects of testosterone are on overall cyto-
kine response to PHA, and not on particular cytokines. To verify this
we performed exploratory analyses examining each cytokine individu-
ally (Tables 4–6). Controlling for baseline cytokine level, age, CRP, and
BMI, testosterone was negatively associated with all 13 PHA-
stimulated cytokines, significantly so with only GM-CSF and IL-8, but
with suggestive trends for IL-2, IL-7, and IL-13 (Table 4). Ten of thir-
teen cytokines had standardized parameter estimates lees than 20.1,
with only IL-1b, IL-6, and IL-4 showing little evidence of association.
Testosterone was not significantly associated with any cytokine follow-
ing LPS stimulation (Table 5), and with LPS stimulation, only two cyto-
kines had standardized parameters less than 20.1 or greater than 0.1:
IL-1b was positively associated with testosterone (b50.148,
p50.132) and IL-2 was negatively associated (b520.125, p50.165).
These results were unchanged when controlling for leukocyte count
(Supporting Information Tables S2–S4).
4 | DISCUSSION
This study tested trade-offs among older Tsimane men between andro-
gens and immune activation biomarkers by examining associations
between endogenous testosterone and mitogen-stimulated cytokine
TABLE 2 Associations between testosterone and overall cytokine response for each mitogen controlling for phenotypic variables
RPMI only LPS only PHA only
DF F-value p-value DF F-value p-value DF F-value p-value
Intercept 1/1,205 0.95 0.329 1/1,200 0.30 0.581 1/1,237 0.16 0.688
Age 1/57 0.03 0.856 1/59 1.54 0.219 1/59 0.10 0.753
BMI 1/57 5.40 0.024 1/59 0.90 0.346 1/59 0.21 0.649
Baseline serum cytokine 1/1,205 65.69 <0.0001 1/1,200 37.67 <0.001 1/1,237 22.68 <0.001
Log CRP 1/57 5.47 0.023 1/59 6.10 0.016 1/59 4.67 0.035
cytokine type 12/1,205 0.04 1.000 12/1,200 0.05 1.000 12/1,237 0.03 1.000
Testosterone 1/57 4.32 0.042 1/59 0.00 0.953 1/59 4.04 0.049
Cytokine type 3 testosterone 12/1,205 0.31 0.988 12/1,200 0.93 0.514 12/1,237 0.53 0.895
Models also contain random effects for batch and subject. Degrees of freedom are estimated by lme and do not reflect sample size due to non-
independence of observations clustered by a random effect term for batch (Pinheiro & Bates, 2006). Cytokines are z-scored within mitogen condition.
Baseline serum cytokines and testosterone are both z-scores. F and p-values are the Wald test statistics for the terms in the model, entered sequen-
tially, so main effects are calculated prior to including interaction terms. Bold indicates statistical significance (p<0.05).
TABLE 3 Associations between testosterone and cytokine response across mitogen conditions controlling for phenotypic variables
Z-scores standardized
across mitogen conditions
Z-scores standardized
within mitogen condition
DF F-value p-value DF F-value p-value
Intercept 1/2,548 0.27 0.604 1/2,548 0.24 0.622
Age 1/62 0.03 0.860 1/62 0.03 0.857
BMI 1/62 0.45 0.504 1/62 0.51 0.478
Baseline cytokine 1/2,548 44.58 <0.001 1/2,548 50.20 <0.001
Log CRP 1/62 5.88 0.018 1/62 5.88 0.018
Cytokine type 12/2,548 0.06 1.000 12/2,548 0.06 1.000
Mitogen type 1/2,548 0.25 0.614 1/2,548 0.01 0.932
Testosterone 1/62 1.25 0.267 1/62 1.04 0.311
Cytokine type 3 mitogen type 12/2,548 81.92 <0.001 12/2,548 0.02 1.000
Mitogen type 3 testosterone 1/2,548 6.70 0.010 1/2,548 6.81 0.009
Cytokine type 3 testosterone 12/2,548 0.67 0.779 12/2,548 0.95 0.499
Models only include PHA and LPS as stimulation types, so do not include RPMI only samples. Models also contain random effects for batch and sub-
ject. Degrees of freedom are estimated by lme and do not reflect sample size due to non-independence of observations clustered by a random effect
term for batch (Pinheiro & Bates, 2006). Serum cytokines and testosterone are both z-scores. Models equate to Figure 1A,B, respectively. F and
p-values are the Wald test statistics for the terms in the model, entered sequentially, so main effects are calculated prior to including interaction terms.
Bold indicates statistical significance (p<0.05).
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levels. Our results indicate that endogenous testosterone is associated
with immuno-modulation, or at least selectively suppressive as
opposed to broadly immunosuppressive. Testosterone is associated
with reduced cytokine responses following stimulation with a T-cell
mitogen, PHA, while testosterone has no significant association with
response to stimulation with a B-cell and monocyte mitogen, LPS.
These results fit within a larger life-history and ecological immunology
literature suggesting that men with higher levels of testosterone down-
regulate some, but not all aspects of immune activation. In this case we
find an association suggesting that cytokine responses to T-cell mito-
gens are downregulated in higher testosterone males. Unlike B-cells,
which can continue to produce relatively long lasting antibodies, cyto-
toxic T-cells must be continually produced and clonally expanded in
large numbers. From an energetic perspective, T-cell mediated immune
activation may be more costly than B-cell mediated immune activation
due to this need to produce many cells (Lochmiller & Deerenberg,
2000). Thus, testosterone appears to selectively downregulate the
most energetically expensive forms of immune activation, which is
expected if testosterone serves an adaptive immuno-modulatory func-
tion, especially in energy-limited subsistence populations.
Stimulation with PHA results in an immune response similar to
that expected with exposure to viral infection (Ceuppens et al., 1988;
Wheelock, 1965), and tends to cause greater changes in IL-2, IL-4, IL-5,
and IL-13 (Table 1, Figure 1A). In animal models, treatment with testos-
terone results in reduced response to viral infections, as measured by
higher viral titers (Lindstr€om, Krakower, Lundstr€om, & Silverin, 2001).
TABLE 4 Effect of testosterone on PHA-stimulated cytokines, controlling for baseline cytokines, CRP, age, and BMI for 109 Tsimane men
Outcome
Testosterone (Z) Baseline cytokine (Z) Log CRP Age BMI
b p b p b p b p b p
GM-CSF 20.217 0.027 0.098 0.285 20.189 0.033 20.005 0.558 20.022 0.552
IL-1b 20.095 0.343 0.005 0.955 20.051 0.563 20.007 0.466 20.036 0.350
IL-2 20.205 0.062 20.022 0.825 20.156 0.109 20.001 0.937 0.014 0.732
IL-7 20.111 0.091 0.218 0.001 20.013 0.828 20.004 0.532 20.017 0.502
IL-6 20.069 0.514 20.161 0.154 20.057 0.590 0.009 0.405 20.029 0.473
IL-8 20.180 0.035 0.004 0.962 20.242 0.002 20.003 0.677 20.066 0.049
TNF-a 20.149 0.135 0.232 0.012 20.064 0.474 0.003 0.727 0.001 0.981
INF-c 20.111 0.161 0.107 0.145 20.158 0.031 0.000 0.959 20.029 0.350
IL-12p70 20.102 0.313 0.330 <0.001 20.054 0.554 0.005 0.614 20.041 0.283
IL-4 20.077 0.477 0.178 0.078 20.061 0.526 0.004 0.729 0.040 0.316
IL-5 20.140 0.144 0.449 <0.001 20.043 0.620 0.000 0.995 0.025 0.475
IL-13 20.202 0.064 0.071 0.484 20.138 0.154 0.000 0.979 0.005 0.892
IL-10 20.104 0.247 0.263 0.004 20.260 0.002 0.001 0.923 20.048 0.164
Each cytokine is modeled separately. Bold indicates statistical significance (p<0.05).
TABLE 5 Effect of testosterone on LPS stimulated cytokines, controlling for baseline cytokines, CRP, age, and BMI for 109 Tsimane men
Outcome
Testosterone (Z) Baseline cytokine (Z) Log CRP Age BMI
b p b p b p b p b p
GM-CSF 20.046 0.601 0.109 0.242 20.159 0.066 20.002 0.807 20.048 0.169
IL-1b 0.148 0.132 20.006 0.951 20.057 0.534 20.003 0.722 0.027 0.468
IL-2 20.125 0.165 0.331 <0.001 20.132 0.120 0.001 0.864 20.084 0.015
IL-7 20.010 0.866 0.200 0.002 20.027 0.649 0.009 0.138 0.010 0.687
IL-6 20.003 0.977 20.197 0.103 20.013 0.902 0.003 0.778 20.016 0.691
IL-8 0.003 0.971 20.021 0.832 20.128 0.114 20.007 0.402 20.047 0.159
TNF-a 20.042 0.561 0.189 0.013 20.071 0.318 0.003 0.721 0.022 0.444
INF-c 0.022 0.716 0.145 0.028 20.052 0.399 20.002 0.765 20.002 0.945
IL-12p70 20.045 0.666 0.195 0.049 20.030 0.753 20.013 0.177 20.044 0.249
IL-4 20.049 0.529 0.285 0.001 20.103 0.170 0.000 0.979 20.017 0.561
IL-5 0.061 0.463 0.568 <0.001 20.076 0.342 20.014 0.081 20.001 0.978
IL-13 20.046 0.613 0.293 0.002 20.245 0.005 20.008 0.360 20.064 0.071
IL-10 0.055 0.504 0.134 0.127 20.220 0.007 0.002 0.782 20.003 0.936
Each cytokine is modeled separately. Bold indicates statistical significance (p<0.05).
TRUMBLE ET AL. | 7
Research on humans indicates that men are more susceptible to viral
infections than women, and also that testosterone is down-regulated
in men infected with diverse viruses ranging from influenza vaccina-
tions to HIV (Grinspoon et al., 1996; Klein, 2000; Simmons & Roney,
2009). If men with higher testosterone have a decreased cytokine
response to viral infection, then reducing levels of testosterone follow-
ing infection would be an optimal response. Indeed, studies find
decreases in testosterone following illness and tissue injury (e.g., Chris-
teff et al., 1988; Muehlenbein & Bribiescas, 2005; Spratt et al., 1993,
2008). Testosterone can be lowered by decreasing hypothalamic-
pituitary-gonadal production, or by increasing aromatization of testos-
terone to estrogen (Spratt et al., 2006). Changes in testosterone and
other biomarkers during and following illness may underlie some sick-
ness behaviors like reduced physical activity and other depressive
symptoms (Shattuck & Muehlenbein, 2015; Stieglitz et al., 2015).
Contrary to the results from PHA stimulation, cytokines produced
by stimulation with LPS were not associated with testosterone. LPS
stimulates B cells as well as macrophages, monocytes, and dendritic
cells. Macrophages in particular may be important in response to injury,
and so the maintenance of their activity with elevated testosterone
might be important. However, B-cells are much more abundant in Tsi-
mane blood compared with industrialized populations, while mono-
cytes are very rare (Blackwell et al., 2016), so much of the LPS
response is likely a B-cell response. Unlike T-cells that are lysed when
destroying infections, B-cells that remain inactive are relatively low
cost reservoirs that can be activated to produce antibodies as needed
(McDade, Georgiev, & Kuzawa, 2016). While the developmental costs
of producing B-cells and immunoglobulins can be high, the mainte-
nance and activation costs are relatively low, as are the collateral costs
in terms of tissue damage when activated (McDade et al., 2016). For a
10 kg human infant, the total cost of producing immunoglobulin
G (IgG) is approximately 0.043% of their daily protein budget, while the
costs of B-cell proliferation during infection is estimated to be
0.00048% of this budget (McDade et al., 2016; Waterlow, 1984).
Immunoglobulins have a half-life of approximately 25 days, and thus
once produced, antibodies have protective effects that require little
additional energetic maintenance or input (Mankarious et al., 1988). On
a-cell-by-cell cost, B-cells and T-cells likely have similar costs. However,
T-cells are two to three times more common in the blood, and for this
reason alone may require more overall resources (Bisset, Lung, Kaelin,
Ludwig, & Dubs, 2004; Blackwell et al., 2016). Thus, from an energetic
perspective, T-cell mediated immune activation may be energetically
costlier than B-cell mediated immune activation. Testosterone perhaps
may be down-regulating the most energetically expensive forms of
immune activation, which is expected if testosterone serves an adapt-
ive immuno-modulatory function.
There are well-characterized impacts of testosterone on both
T-cells and B-cells. Evidence suggests that testosterone can bind to,
and actively inhibit T-cell differentiation and proliferation (Benten et al.,
1999; Kissick et al., 2014; McMurray, Suwannaroj, Ndebele, & Jenkins,
2001). B-cells do not express surface androgen receptors (Benten,
Stephan, & Wunderlich, 2002), and testosterone does not appear to be
associated with differences in B-cell proliferation (McMurray et al.,
2001), though treatment with exogenous testosterone does decrease
antibody production in animal models (Kanda, Tsuchida, & Tamaki,
1996). Previous studies report positive associations between andro-
gens and anti-inflammatory cytokines (Liva & Voskuhl, 2001; Malkin
et al., 2004). While the results in the present study do not replicate
these findings, there are several confounding factors that make direct
comparisons difficult. First, those studies used exogenous testosterone
administration, which while an excellent way to isolate the impact of
testosterone on cytokines may not be ecologically valid, as many
aspects of physiology other than just androgens are modified when
androgens naturally increase. Other studies using exercise to
TABLE 6 Effect of testosterone on unstimulated cytokines in RPMI alone, controlling for baseline cytokines, CRP, age, and BMI for 109 Tsi-
mane men
Outcome
Testosterone (Z) Baseline cytokine (Z) Log CRP Age BMI
b p b p b p b p b p
GM-CSF 20.083 0.257 0.045 0.555 20.122 0.096 20.006 0.413 20.064 0.041
IL-1b 20.025 0.715 0.175 0.012 20.139 0.044 0.002 0.796 20.027 0.354
IL-2 20.105 0.175 0.215 0.010 20.240 0.002 20.001 0.899 20.073 0.022
IL-7 20.012 0.897 0.388 <0.001 20.064 0.486 0.008 0.412 20.035 0.345
IL-6 20.144 0.089 0.592 <0.001 20.124 0.126 20.007 0.379 20.021 0.530
IL-8 20.114 0.070 0.049 0.437 20.118 0.062 20.008 0.240 20.025 0.360
TNF-a 20.088 0.354 0.281 0.004 20.079 0.391 20.003 0.778 20.071 0.059
INF-c 20.062 0.424 0.337 <0.001 20.034 0.651 20.006 0.470 20.043 0.178
IL-12p70 20.119 0.122 0.731 <0.001 0.032 0.660 0.008 0.287 20.002 0.950
IL-4 20.141 0.086 20.168 0.066 20.055 0.529 0.007 0.389 20.080 0.020
IL-5 20.043 0.588 0.205 0.015 0.034 0.669 0.010 0.205 0.002 0.955
IL-13 20.146 0.072 20.044 0.643 20.215 0.008 20.001 0.921 20.090 0.009
IL-10 20.090 0.308 0.199 0.049 20.112 0.194 20.001 0.935 20.063 0.082
Each cytokine is modeled separately. Bold indicates statistical significance (p<0.05).
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naturalistically manipulate testosterone do not find the same associa-
tions between testosterone and IL-10 (Benini Prado Nunes, Orsatti,
Barcelos, & Orsatti, 2015). Secondly, Tsimane have significantly lower
levels of age-matched testosterone than males living in industrialized
populations (Trumble et al., 2012), and thus the low levels seen in this
population, and perhaps throughout much of human evolution, may
potentially have had less of an impact on anti-inflammatory cytokines
than the relatively high levels seen in men in industrialized populations
and men taking exogenous testosterone.
Our study finds associations between endogenous testosterone
and cytokine production. However, there may be multiple mechanisms
through which this effect could occur. Endogenous testosterone is
present in the blood samples used for stimulation, and may act directly
on leukocytes at the time of stimulation. Alternatively, long term differ-
ences in testosterone may have effects on leukocyte phenotypes that
affect responsiveness to stimulation, irrespective of levels in the blood
at the particular time of stimulation. Androgen receptors are present
on T-cells (Benten et al., 1999), but their numbers might be dynamically
regulated in response to baseline androgen levels and other feedback
mechanisms. Additionally, developmental changes at early ages may
have led to differences between individuals in both testosterone and
immune function, leading to associations that are not necessarily
causal, but rather correlates of other phenotypic variables.
These hypotheses are not mutually exclusive, and we think it likely
that all three of these pathways might be important. Our results sug-
gest that testosterone is not associated with baseline cytokines or leu-
kocyte counts, yet there are other ways immune function might vary
as a function of disease or developmental history. Future studies will
be needed to separate these causal mechanisms more carefully.
There are several reasons why our results may differ from other
studies of the ICHH. The immune system is multifaceted and these
studies differ in the type of immune activation being studied. While a
recent meta-analysis found support for testosterone down-regulating
many aspects of immune function, it notes significantly more variation
and less consistency across 19 studies examining impacts of testoster-
one on cytokines compared with other markers of immune function
(cell-mediated, humoral, parasitic white blood cell based studies) (Foo
et al., 2016). Cytokines are just one aspect of immunity, and while the
results reported here are consistent with the notion that testosterone
is immuno-modulatory in contrast to the ICHH as originally formulated,
further research is needed. A more direct test of immuno-modulation
would involve manipulation of testosterone levels, though such an
experimental design would have reduced ecological validity. Addition-
ally, the participants in this study were on average older than some
previous studies (see Section 4.1 below).
Trade-offs between reproduction and survival are one of the most
studied life-history trade-offs. Quasi-experimental studies like the one
conducted here suggest that ceteris paribus, higher testosterone males
show down-regulated immune response to some, but not all, compo-
nents of immune function, implicating testosterone as a potential
immuno-suppressant to some of the energetically costlier aspects of
human immune function. That said, there is no single global measure of
immune function; instead millions of years of evolution have shaped a
system to fight multiple pathogens in myriad ways through numerous
physiological pathways. So while higher endogenous levels of testos-
terone may down-regulate some aspects of immune function (e.g.,
cytokine response to T-cell mitogens), that does not mean that testos-
terone is generally immuno-suppressive; indeed cytokine responses to
B-cell mitogens were largely unaffected by testosterone. Additionally,
relatively long-lived humans invest more in some aspects of immune
function and survival compared with species with faster life histories (i.
e., murine models) which prioritize early reproduction (Lee, 2006).
Thus, while we find little evidence of the ICHH in humans, these results
may not be applicable to other species with faster life history
strategies.
Much of the previous research into immune-testosterone links
have been conducted in seasonally breeding birds or mice, which may
not offer a good model of human immune function (Greenman, Martin,
& Hau, 2005; Warren et al., 2014). In seasonal breeders, more than just
circulating testosterone changes during the mating season; major
changes are observed in energy expenditure, sleep, body composition,
social behavior, and food consumption, all of which can alter immune
function (Greenman et al., 2005). Tsimane are exposed to high patho-
gen loads (Blackwell et al., 2015; Gurven et al., 2008) which also vary
seasonally and may predispose their immune system to be less reactive
to minor insults like antigen stimulation (McDade, Rutherford, Adair, &
Kuzawa, 2010), or alternatively primed to respond to any type of insult.
These alternative hypotheses require further testing. Because Tsimane
men have lower levels of testosterone compared with men in industri-
alized populations (Ellison et al., 2002; Trumble et al., 2012), Tsimane
men may not experience the kind of generalized immunosuppression
observed when superphysiological levels of testosterone are exoge-
nously applied to nonhuman animal models (Duffy et al., 2000; Peters,
2000; Poiani et al., 2000; Yao et al., 2003). Previous research among
the Tsimane also found no evidence that disease symptoms (e.g., diar-
rhea, respiratory illness, injuries) from clinical exams were associated
with testosterone in a small sample of men (Trumble et al., 2013).
4.1 | Strengths and limitations
A strength of our study design is that we tested the impact of two dif-
ferent mitogens across 13 cytokines; had we just focused on only PHA
or LPS we would have had different results and interpretations. While
ex vivo whole blood antigen stimulation only provides a small window
into the role of testosterone in modulating immune function, it is also a
powerful tool that allows us to examine immune responses that would
otherwise be unethical or impossible to study in non-laboratory set-
tings. This experimental protocol also avoids confounding by ensuring
that all specimens receive the same pathogenic exposure, and that
androgens do not down-regulate following illness, both of which are
critical for understanding the role of these steroids in affecting immune
function. While antigen stimulation is beneficial for isolating the role of
steroids on specific aspects of immune activation, it is not guaranteed
that the response from ex vivo stimulation will match the myriad
potential additional responses in a living human. Nonetheless this
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demonstrates the importance of field-friendly experimental manipula-
tions; had this been a purely observational study of baseline cytokines
and testosterone we would have observed no relationship between
testosterone and circulating cytokines (see results above). This study is
also limited by focusing solely on males, and on older males over age
40; the immuno-modulatory effects of testosterone could potentially
be stronger in younger males who are investing more energy in repro-
ductive effort. Additionally, given changes in immune function with age
among the Tsimane (Blackwell et al., 2016), it is possible that baseline
cytokines, or cytokine responsiveness may differ at younger ages. This
does not diminish the results of this study; with modal ages of death in
the 70s, a 45-year-old Tsimane male can expect to live an additional
25.6 years of life (Gurven, Kaplan, & Supa, 2007), and thus trade-offs
between androgens and immune function still have important conse-
quences even at later ages. With the rise of testosterone replacement
therapies in industrialized populations (Gan, Pattman, Hs Pearce, &
Quinton, 2013), these results could also be of interest to the wider bio-
medical community as more older men are exposed to higher doses of
testosterone. Some might argue that results from populations like the
Tsimane are not generalizable to industrialized populations, but we
argue that they represent a crucial step toward understanding human
immune and endocrine physiology, which evolved under very different
conditions than those observed in modern settings with less pathogen
exposure.
5 | CONCLUSIONS
Testosterone is more strongly associated with cytokine down-
regulation in response to PHA stimulation, which induces a largely
T-cell mediated response; stimulation with LPS (largely biased toward
B-cell immunity) did not result in generalized immunosuppression. It is
clear from these results that steroid hormones are associated with dif-
ferential cytokine responses to different mitogen types, a result that
would not have been found focusing solely on one mitogen or one bio-
marker of immune function, or if relying only upon (unstimulated) base-
line circulatory cytokines. Future studies will focus on the differential
impacts of testosterone and other steroid hormones on cytokine
response to additional mitogen types and using a wider age range and
across sexes, to better understand the role of such hormones in modu-
lating immune function. Parasites, bacterial infections, and viruses were
all major selective pressures throughout human evolution, and under-
standing the impact of steroids on immune responses to each of these
infections can provide greater understanding of trade-offs between
reproductively beneficial androgens and longevity.
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